This study is for patients with multiple myeloma, a type of blood cancer. It is testing a new drug called BGB-11417 alone and combined with other drugs, dexamethasone and carfilzomib. The study has two parts: dose escalation (finding the right dose) and cohort expansion (testing in more people). Participants must have tried other treatments that didn’t work, and meet specific health requirements. They should not have other serious health issues like heart problems or infections.
- Length: The study involves multiple parts, so it may take several months.
- Visits: Participants may have to visit the clinic multiple times for treatment and tests.
- Risks: There may be side effects from the drugs used in this study.
Before joining, participants will undergo tests to ensure they meet the study's health criteria. This study is crucial for finding new ways to treat multiple myeloma more effectively. Discuss with your doctor if this study might be suitable for you.
How understandable was the trial content above?
Hard to understand
Easy to understand